ROBERT VISSING: Open Payments
NPI 1457352395 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 8 payments from 8 companies in 2025. Trend: 2023 $608 · 2024 $715 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 1 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $121 |
| AstraZeneca Pharmaceuticals LP | 1 | $114 |
| Inspire Medical Systems, Inc. | 1 | $101 |
| Lilly USA, LLC | 1 | $97 |
| TMS NeuroHealth Centers Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $14 |
| ABBVIE INC. | 1 | $14 |
Products named: Korlym, Kerendia, BREZTRI, INSPIRE, ZEPBOUND, TMS NeuroHealth Centers Inc., Ozempic, UBRELVY.
Industry payments across MD — which companies pay providers there.
